======= STOX1 ======= == Gene Information == * **Official Symbol**: STOX1 * **Official Name**: storkhead box 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=219736|219736]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZVD7|Q6ZVD7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=STOX1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STOX1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609397|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene may function as a DNA binding protein. Mutations in this gene are associated with pre-eclampsia/eclampsia 4 (PEE4). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]. * **UniProt Summary**: N/A |Stork head| |regulation of otic vesicle morphogenesis| |positive regulation of otic vesicle morphogenesis| |regulation of mitochondrial DNA metabolic process| |cellular response to nitrosative stress| |response to nitrosative stress| |positive regulation of G2/M transition of mitotic cell cycle| |positive regulation of peptidyl-threonine phosphorylation| |positive regulation of cell cycle G2/M phase transition| |positive regulation of morphogenesis of an epithelium| |positive regulation of cyclin-dependent protein kinase activity| |positive regulation of embryonic development| |regulation of peptidyl-threonine phosphorylation| |regulation of mitochondrial membrane potential| |positive regulation of mitotic cell cycle phase transition| |regulation of transcription from RNA polymerase II promoter in response to hypoxia| |positive regulation of animal organ morphogenesis| |regulation of response to oxidative stress| |positive regulation of cell cycle phase transition| |regulation of cyclin-dependent protein kinase activity| |positive regulation of peptidyl-serine phosphorylation| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |regulation of embryonic development| |fibrillar center| |cell cortex| |regulation of peptidyl-serine phosphorylation| |positive regulation of mitotic cell cycle| |positive regulation of protein kinase B signaling| |regulation of morphogenesis of an epithelium| |regulation of mitochondrion organization| |cellular response to hypoxia| |positive regulation of epithelial cell proliferation| |inner ear development| |regulation of G2/M transition of mitotic cell cycle| |cellular response to decreased oxygen levels| |regulation of cell cycle G2/M phase transition| |cellular response to oxygen levels| |regulation of protein kinase B signaling| |ear development| |regulation of animal organ morphogenesis| |positive regulation of cell cycle process| |RNA polymerase II regulatory region sequence-specific DNA binding| |regulation of epithelial cell proliferation| |response to hypoxia| |regulation of DNA metabolic process| |response to decreased oxygen levels| |positive regulation of cell cycle| |response to oxygen levels| |regulation of mitotic cell cycle phase transition| |regulation of membrane potential| |regulation of cell cycle phase transition| |centrosome| |cell division| |positive regulation of protein kinase activity| |sensory organ development| |positive regulation of kinase activity| |regulation of mitotic cell cycle| |positive regulation of transferase activity| |regulation of cell cycle process| |regulation of protein kinase activity| |regulation of kinase activity| |positive regulation of cell population proliferation| |regulation of transferase activity| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |response to abiotic stimulus| |regulation of cell cycle| |positive regulation of protein modification process| |regulation of organelle organization| |cell cycle| |positive regulation of developmental process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of response to stress| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |positive regulation of signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|1.72| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.85| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18206 * **Expression level (log2 read counts)**: 3.36 {{:chemogenomics:nalm6 dist.png?nolink |}}